European Journal of Cancer
Volume 48, Issue 3 , Pages 396-406 , February 2012

The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy

  • Emma Hernlund

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Maria Hägg Olofsson

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Walid Fayad

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Mårten Fryknäs

      Affiliations

    • Division of Clinical Pharmacology, Department of Medical Sciences, Uppsala University Hospital, 751 85 Uppsala, Sweden
    • ,
  • Karolina Lesiak-Mieczkowska

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Xiaonan Zhang

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Slavica Brnjic

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Vivien Schmidt

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Padraig D’Arcy

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Tobias Sjöblom

      Affiliations

    • Department of Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden
    • ,
  • Angelo De Milito

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • ,
  • Rolf Larsson

      Affiliations

    • Division of Clinical Pharmacology, Department of Medical Sciences, Uppsala University Hospital, 751 85 Uppsala, Sweden
    • ,
  • Stig Linder

      Affiliations

    • Department of Oncology & Pathology, Karolinska Institute, 171 76 Stockholm, Sweden
    • Corresponding Author InformationCorresponding author: Address: Cancer Center Karolinska, CCK R8:00, Karolinska Hospital, S-171 76 Stockholm, Sweden.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(11)00906-3

doi: 10.1016/j.ejca.2011.11.013

European Journal of Cancer
Volume 48, Issue 3 , Pages 396-406 , February 2012

Article Tools

* Image Usage & Resolution